摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(5-(3-formyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide | 1467098-48-1

中文名称
——
中文别名
——
英文名称
N-(5-(3-formyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide
英文别名
N-[5-[3-formyl-1-(oxan-2-yl)indazol-5-yl]pyridin-3-yl]-3-methylbutanamide
N-(5-(3-formyl-1-(tetrahydro-2H-pyran-2-yl)-1H-indazol-5-yl)pyridin-3-yl)-3-methylbutanamide化学式
CAS
1467098-48-1
化学式
C23H26N4O3
mdl
——
分子量
406.484
InChiKey
LLPLATUEPPIYKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    30
  • 可旋转键数:
    6
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.39
  • 拓扑面积:
    86.1
  • 氢给体数:
    1
  • 氢受体数:
    5

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • [EN] FUSED RING COMPOUND, AND INTERMEDIATE THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF<br/>[FR] COMPOSÉ À CYCLES FUSIONNÉS, ET INTERMÉDIAIRE DE CELUI-CI, PROCÉDÉ DE PRÉPARATION ASSOCIÉ ET APPLICATION<br/>[ZH] 稠环化合物及其中间体、制备方法和应用
    申请人:JIANGSU KDN PHARMACEUTICAL TECH CO LTD
    公开号:WO2022012058A1
    公开(公告)日:2022-01-20
    提供了一种如式Ia或Ib所示的化合物、其药学上可接受的盐、其水合物、其溶剂化物、其多晶型、其代谢产物、其立体异构体、其互变异构体或其前药。该化合物作为Wnt抑制剂以及间充质干细胞诱导剂,对sox9、Ⅰ型胶原、Ⅹ型胶原、成骨转录基因和碱性磷酸酶中的一种或多种具有较好的诱导作用,进而可以用来制备治疗和/或改善相关的疾病和病症的药物。
  • [EN] INDAZOLE INHIBITORS OF THE WNT SIGNAL PATHWAY AND THERAPEUTIC USES THEREOF<br/>[FR] INHIBITEURS D'INDAZOLE DU TRAJET DE SIGNAL DE WNT ET LEURS UTILISATIONS THÉRAPEUTIQUES
    申请人:SAMUMED LLC
    公开号:WO2013151708A1
    公开(公告)日:2013-10-10
    Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states. One embodiment disclosed herein includes a compound having the structure of Formula I:
    本发明揭示了用于治疗各种疾病和病理的吲唑化合物。更具体地,本发明涉及使用吲唑化合物或其类似物治疗由Wnt通路信号激活引起的障碍(例如癌症、异常细胞增殖、血管生成、阿尔茨海默病、肺部疾病和骨关节炎),调节由Wnt通路信号介导的细胞事件,以及由于Wnt通路和/或一个或多个Wnt信号传递组分的突变或失调而引起的遗传疾病和神经状况/紊乱/疾病。还提供了治疗Wnt相关疾病状态的方法。本文所披露的一种实施例包括具有式I结构的化合物:
  • Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof
    申请人:Samumed, LLC
    公开号:US08664241B2
    公开(公告)日:2014-03-04
    Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.
    本发明揭示了用于治疗各种疾病和病理的吲唑化合物。更具体地,本发明涉及使用吲唑化合物或其类似物治疗通过激活Wnt通路信号(例如癌症,异常细胞增殖,血管生成,阿尔茨海默病,肺病和骨关节炎)特征的紊乱,调节通过Wnt通路信号介导的细胞事件,以及由于Wnt通路和/或一个或多个Wnt信号组分的突变或失调而引起的遗传疾病和神经状况/失调/疾病。还提供了治疗Wnt相关疾病状态的方法。
  • Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof
    申请人:Samumed, LLC
    公开号:US09199991B2
    公开(公告)日:2015-12-01
    Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present invention concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.
    本发明公开了用于治疗各种疾病和病理的吲唑化合物。更具体地说,本发明涉及使用吲唑化合物或其类似物,治疗由Wnt通路信号激活所特征的疾病(例如癌症、异常细胞增殖、血管生成、阿尔茨海默病、肺病和骨关节炎),调节由Wnt通路信号介导的细胞事件,以及由于Wnt通路和/或一个或多个Wnt信号传导组分的突变或失调而引起的遗传疾病和神经系统疾病/紊乱/疾病。还提供了治疗Wnt相关疾病状态的方法。
  • [EN] BENZOPYRAZOLE COMPOUND AND INTERMEDIATE, PREPARATION METHOD, AND APPLICATION THEREOF<br/>[FR] COMPOSÉ BENZOPYRAZOLE ET INTERMÉDIAIRE, PROCÉDÉ DE PRÉPARATION CORRESPONDANT ET UTILISATION ASSOCIÉE<br/>[ZH] 苯并吡唑类化合物及其中间体、制备方法和应用
    申请人:JIANGSU KDN PHARMACEUTICAL TECH CO LTD
    公开号:WO2021121420A1
    公开(公告)日:2021-06-24
    一种苯并吡唑类化合物及其中间体、制备方法和应用。苯并吡唑类化合物如式I所示。式I所示化合物作为Wnt途径中一种或多种蛋白的抑制剂,以及对蛋白多糖、Ⅱ型胶原、sox9、Ⅰ型胶原、Ⅹ型胶原、成骨转录基因和碱性磷酸酶中的一种或多种具有较好的诱导作用,进而可以用来治疗和/或预防相关疾病。
查看更多